<DOC>
	<DOCNO>NCT00613249</DOCNO>
	<brief_summary>IPM 012 double-blind , randomize , placebo-controlled phase I study conduct one research center Belgium among 36 healthy , HIV-negative woman 18-40 year age , randomize 1:1:1 ratio ass plasma , vaginal fluid vaginal tissue level pharmacokinetics dapivirine apply either Dapivirine Gel 4750 , 0.05 % , 2.5g Dapivirine Gel 4789 , 0.05 % , 2.5g intravaginally 11 day ( 1 day follow 3 day washout period 10 consecutive day ) ; assess safety gel compare intravaginal HEC-based universal placebo gel .</brief_summary>
	<brief_title>A Phase I Pharmacokinetics Safety Study Two Dapivirine Intravaginal Gels</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Women 18 40 year age , inclusive Willing able give write informed consent Available visit consent follow procedure Healthy , base medical history , vital sign , physical examination , urinalysis , laboratory evaluation genital infection laboratory evaluation hematology , liver renal function HIVnegative determine HIV1 ELISA test enrollment Willing abstain sexual activity duration study On stable oral contraceptive regimen 2 month prior enrollment willing continue Upon pelvic/speculum examination , cervix vagina appear normal Willing refrain use vaginal product 14 day prior enrollment duration study History alcoholism , drug abuse , psychosis , antagonistic personality , poor motivation emotional intellectual problem likely invalidate inform consent process adversely impact adherence protocol requirement History sensitivity/allergy component study product latex Currently pregnant breastfeeing , within 3 month last pregnancy outcome Currently within one month participate clinical research study History current diagnosis and/or treatment STD within last three month prior enrollment Current vulvar , vaginal cervical symptoms/abnormalities determine pelvic/speculum exam colposcopy could influence study result History significant urogenital uterine prolapse , undiagnosed vaginal bleeding urethral obstruction within last 3 month Current noniatrogenic pelvic/colposcopic exam finding involve deep epithelial disruption Smoking 10 cigarette day</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>HIV-1 Infection</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>